ZapMax Capsules recalled over undeclared sildenafil
- Recall date
- November 4, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Boulla LLC recalls ZapMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZapMax, 2108 N St. Sacramento, CA 95816, www.zap…
- Recall number
- D-0086-2025
- FDA classification
- Class I
- Brand / firm
- Boulla LLC
- Sold / distributed
- Nationwide within the United States
Why it was recalled
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
ZapMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZapMax, 2108 N St. Sacramento, CA 95816, www.zapmax.com
Get recall alerts
Free email alert whenever Boulla LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Boulla LLC